Osteonecrosis of the jaw

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current Rheumatology Reports

• Publication date

  2008-05-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S11926-008-0018-5PMID 18460263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

  2007cited by this paper
• Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis.

  2007cited by this paper
• Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

  2007influential reference
• Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.

  2007cited by this paper
• Possible association between diabetes and bisphosphonate-related jaw osteonecrosis.

  2007cited by this paper
• Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

  2007cited by this paper
• Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?

  2007cited by this paper
• Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review.

  2007cited by this paper
• Imaging Findings of Bisphosphonate-Associated Osteonecrosis of the Jaws

  2007cited by this paper
• Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome

  2007cited by this paper
• Zoledronic acid and clinical fractures and mortality after hip fracture.

  2007cited by this paper
• Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

  2007cited by this paper
• [Necrosis of the jaws under bisphosphonate therapy].

  2006cited by this paper
• Nekrosen der Kieferknochen unter Bisphosphonattherapie

  2006cited by this paper
• Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.

  2006cited by this paper
• Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis

  2006cited by this paper
• Bisphosphonates and osteonecrosis of the jaw.

  2006cited by this paper
• Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?

  2006cited by this paper
• Osteonecrosis of the Mandible or Maxilla Associated with the use of New Generation Bisphosphonates

  2006cited by this paper
• Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy.

  2006cited by this paper
• Bisphosphonate‐associated osteonecrosis of the auditory canal

  2006cited by this paper
• Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws

  2006cited by this paper
• Adverse oral sequelae to bisphosphonate administration.

  2005cited by this paper
• [Bisphosphonates-related jaw osteonecrosis].

  2005cited by this paper
• Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper.

  2005cited by this paper
• Ostéonécrose des maxillaires chez des patients traités par bisphosphonates

  2005cited by this paper
• The dental implications of bisphosphonates and bone disease.

  2005cited by this paper
• Analysis of Frequency and Risk Factors for Developing Bisphosphonate Associated Osteonecrosis of the Jaw.

  2005cited by this paper
• Bisphosphonates and osteonecrosis of the jaw

  2005cited by this paper
• Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

  2004cited by this paper
• Current concepts of the management of dental extractions for patients taking warfarin.

  2003cited by this paper
• Bisphosphanates and oral cavity avascular bone necrosis.

  2003cited by this paper
• Bisphosphonates and avascular necrosis of the jaws.

  2003cited by this paper
• Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

  2003cited by this paper
• Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.

  2002cited by this paper
• Cytokine expression in periodontal health and disease.

  1998cited by this paper
• Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: a case report.

  1995cited by this paper

• Classical non-traumatic osteonecrosis versus osteonecrosis of the jaw: Distinct manifestations of a shared pathophysiological spectrum.

  2026cites this paper
• MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ): CURRENT EVIDENCE ON ETIOLOGY, PATHOGENESIS, DIAGNOSIS, AND MANAGEMENT:A SCOPING REVIEW

  2026cites this paper
• Medial femoral condyle free flap for reconstructions of medication related osteonecrosis of the jaw

  2026influential citation
• Unraveling Jawbone Susceptibility: Distinctive Features Underlying Medication-Related Osteonecrosis

  2026cites this paper
• Navigating Stomatologic Complications Secondary to Antineoplastic Agents—A Comprehensive Review

  2025cites this paper
• Prevention of bisphosphonate-related osteonecrosis of the jaw with basic fibroblast growth factor: an experimental study in rats

  2025cites this paper
• Buccodental Toxicities Induced by Tyrosine Kinase Inhibitors in Patients Diagnosed with Renal Cell Carcinoma—A Literature Review

  2025cites this paper
• Imaging Modalities in Medication-Related Osteonecrosis of the Jaw: A Narrative Review of Diagnostic Findings and Staging

  2025cites this paper
• Modulating the Gut Microbiota to Target Neuroinflammation, Cognition and Mood: A Systematic Review of Human Studies with Relevance to Fibromyalgia

  2025cites this paper
• A case series and review of canine idiopathic osteonecrosis of the jaw

  2025cites this paper
• Comparative Evaluation of Platelet-Rich Fibrin (PRF) and Concentrated Growth Factor (CGF) as Carriers for Antibiotics—In Vitro Study

  2025cites this paper
• Autofluorescence-Guided Surgery in the Management of Osteonecrosis of the Jaw: Correlation Between Bone Autofluorescence and Histopathological Findings in 56 Samples

  2025cites this paper
• Recent Stem-Cell-Based and Stem-Cell-Free Possibilities for the Therapeutic Management of the Osteonecrosis of the Jaw

  2025cites this paper
• Differential risk of autoimmune disorders in non-traumatic osteonecrosis: clue to pathogenesis

  2025cites this paper
• Prevalence of Free Flap Failure in Patients Undergoing Reconstruction for Medication-Related Osteonecrosis of the Jaw: A Systematic Review and Meta-Analysis

  2025cites this paper
• Autologous Platelet Concentrates in the Management of Medication-Related Osteonecrosis of the Jaw: A Systematic Review

  2025cites this paper
• Osteonecrosis in the context of denosumab - Perspective of the bone metabolism specialist and the maxillofacial specialist

  2024cites this paper
• Antiresorptive agents enhance ossification of free flap reconstructions of the mandible: a radiological retrospective cohort study

  2024cites this paper
• How we manage medication-related osteonecrosis of the jaw

  2024cites this paper
• Exploring the Impact of Novel Anti-Cancer Therapies on Jaw Osteonecrosis and Other Bones: A Comprehensive Review

  2024cites this paper
• Fotobiomodulación con oxígeno activo y lactoferrina en el tratamiento de osteonecrosis de la mandíbula asociada a medicamentos. Reporte de caso

  2024cites this paper
• Survey of the association between tooth extraction and development of medication-related osteonecrosis of the jaw in patients undergoing cancer treatment with bone-modifying agents

  2024influential citation
• Prevention and management of drug‐induced osteonecrosis of the jaws using platelet‐rich fibrin: A clinical feasibility study

  2023cites this paper
• Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid

  2023cites this paper
• A Narrative Review of Osteonecrosis of the Jaw: What a Clinician Should Know

  2023cites this paper
• Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): a critical update and consensus statement

  2023cites this paper
• Magnetic resonance imaging in the diagnosis of periodontal and periapical disease

  2023cites this paper
• Sixty-Month Follow Up of Clinical MRONJ Cases Treated with CGF and Piezosurgery

  2023cites this paper
• Quantitative indices for cone-beam CT assessment of Medication-Related Osteonecrosis of the Jaw – a scoping review

  2022cites this paper
• Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: A case-control study

  2022cites this paper
• Incidence and risk factors for medication‐related osteonecrosis after tooth extraction in cancer patients—A systematic review

  2022influential citation
• The road of NSCLC stem cells toward bone metastases

  2022cites this paper
• A Toxin-Free Mouth is More Important Than Beautiful Teeth

  2022cites this paper
• Occlusal Trauma and Bisphosphonate-Related Osteonecrosis of the Jaw in Mice

  2021cites this paper
• Cells Derived from Human Long Bone Appear More Differentiated and More Actively Stimulate Osteoclastogenesis Compared to Alveolar Bone-Derived Cells

  2020cites this paper
• The effect of melatonin on prevention of bisphosphonate-related osteonecrosis of the jaw: an animal study in rats

  2020cites this paper
• THE USE OF DENOSUMAB IN GIANT CELL TUMORS IN THE SACRUM

  2020cites this paper
• Therapeutic approach and management algorithms in medication-related osteonecrosis of the jaw (MONJ): recommendations of a multidisciplinary group of experts

  2020cites this paper
• “MRONJ: Dentistry and Physician Events under Bisphosphonates, Denosumab and Antiangiogenic Drugs”

  2020cites this paper
• Multiple vertebral fractures after suspension of denosumab. A series of 56 cases

  2020cites this paper
• Osteonecrosis of the jaw associated with intravenous administration ofbisphosphonates in palliative home care – a case report

  2020cites this paper
• The role of OPG/RANKL/RANK signaling pathway in the pathogenesis of giant-cell tumor of bone

  2020influential citation
• Clinical question:What is the evidence for the use of bisphosphonates in the treatment of bone pain?

  2019influential citation
• Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments: Systematic review

  2019cites this paper
• Clinical pathologies of bone fracture modelled in zebrafish

  2019cites this paper
• Mandibular Osteonecrosis Associated with Antacid Therapy (Esomeprazole)

  2019cites this paper
• Preliminary safety assessment of oridonin in zebrafish

  2019cites this paper
• Prevalence in Rice Rats with Generalized Periodontitis

  2019cites this paper
• Osteoporosis Treatment Based on Fracture Risk: A Quality of Care Study

  2018cites this paper
• CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.

  2018cites this paper
• The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention

  2018cites this paper
• Osteonecrosis of the Jaw Induced by Biphosphonates: About 2 Clinical Cases

  2018cites this paper
• BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW: THE CURRENT STATUS OF THE PROBLEM, RECOMMENDATIONS FOR PREVENTION AND TREATMENT TACTICS

  2018cites this paper
• Coronary artery disease: New Insights into revascularization treatment of diabetic patients.

  2017cites this paper
• Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study

  2017cites this paper
• Random Electromyostimulation Promotes Osteogenesis and the Mechanical Properties of Rat Bones

  2017cites this paper
• Osteonecrosis de los maxilares: actualización a propósito de un caso clínico

  2017influential citation
• Osteogenesis imperfecta: diagnosis and treatment

  2017cites this paper
• Guías Argentinas para el diagnóstico, la prevención y el tratamiento de la osteoporosis 2015

  2017cites this paper
• Resection and microvascular reconstruction of bisphosphonate‐related osteonecrosis of the jaw: The role of microvascular reconstruction

  2016cites this paper
• Endodontic Re-treatment of a Tooth with a Floor Perforation in a Patient in Treatment with Oral Bisphosphonate

  2016cites this paper
• Prevenzione e management odontoiatrico dei pazienti oncologici a rischio di osteonecrosi delle ossa mascellari da farmaci

  2016cites this paper
• Effects of Zoledronate During Simulated Weightlessness on Bone Structure and Mechanics

  2016cites this paper
• Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases

  2016cites this paper
• DENOSUMAB-A NEW THERAPEUTIC OPTION FOR OSTEOPOROSIS

  2015cites this paper
• Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.

  2015cites this paper
• Permanganometry for the Determination of Strontium and Strontium Ranelate in Pharmaceutical Formulation for the Treatment of Postmenopausal Osteoporosis

  2015cites this paper
• Osteonecrosis of the Jaw Related to Oral Bisphosphonate Treatment: A Clinical Case

  2014cites this paper
• Posible osteonecrosis mandibular inducida por denosumab en el tratamiento de la osteoporosis: a propósito de un caso

  2014cites this paper
• Simultaneous determination of strontium ranelate and aspartame in pharmaceutical formulation for the treatment of postmenopausal osteoporosis by capillary zone electrophoresis

  2014cites this paper
• Important aspects regarding the role of microorganisms in bisphosphonate-related osteonecrosis of the jaws.

  2014cites this paper
• Bisphosphonate-Related Osteonecrosis of the Jaw: Specificities

  2014cites this paper
• A Review of Biopsy in Dentistry: Principles, Techniques, and Considerations

  2014cites this paper
• Osteonecrosis of the jaw in patient with denosumab therapy.

  2014cites this paper
• DOTTORATO DI RICERCA IN BIOPATOLOGIA THE COMBINED USE OF PRP AND ER , CR : YSGG LASER IN THE TREATMENT OF OSTEONECROSIS OF THE JAWS

  2014cites this paper
• [Guidelines for the diagnosis, prevention and treatment of osteoporosis, 2012].

  2013cites this paper
• Skeletal aging: from bench to bed side.

  2013cites this paper
• The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK guideline for clinical management of postmenopausal osteoporosis in Hong Kong.

  2013cites this paper
• Ostéonécroses des maxillaires dues aux bisphosphonates administrés par voie intraveineuse : incidence et facteurs de risque

  2013cites this paper
• Radiographic findings of bisphosphonate-related osteomyelitis of the jaw: investigation of the diagnostic points by comparison with radiation osteomyelitis, suppurative osteomyelitis, and diffuse sclerosing osteomyelitis

  2013cites this paper
• Guías 2012 para el diagnóstico, la prevención y el tratamiento de la osteoporosis

  2013cites this paper
• Skeletal Aging: From Bench to Bed Side

  2013cites this paper
• For whom the bell tolls: distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases.

  2013cites this paper
• La osteonecrosis asociada al tratamiento con bifosfonatos en osteoporosis primaria

  2012cites this paper
• Risikofaktoren und klinische Präsentation

  2012cites this paper
• Close to the bone : investigations into bone tissue mineralisation and mechanobiology of osteoporosis

  2012cites this paper
• Bisphosphonates and osteonecrosis of the jaw : a multidisciplinary approach

  2012cites this paper
• How Dentistry Can Help Fight Osteoporosis

  2012cites this paper
• Ipilimumab in melanoma

  2012cites this paper
• Aging, Systemic Disease and Oral Health: Implications for Women Worldwide (Part II)

  2012cites this paper
• Osteonecrosis of the jaws in patients treated with bisphosphonates

  2012cites this paper
• Pharmacotherapy of Paget's disease of bone

  2012cites this paper
• A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling

  2011cites this paper
• Bone-Within-Bone Appearance: A Red Flag for Biphosphonate-Associated Osteonecrosis of the Jaw

  2011cites this paper
• The effects of aging and remodeling on bone quality and microdamage

  2011cites this paper
• Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients.

  2011cites this paper
• Medicamentos para o tratamento da osteoporose: revisão

  2011cites this paper
• Bisphosphonate therapy for skeletal malignancies and metastases: impact on jaw bones and prosthodontic concerns.

  2011cites this paper
• Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic, hormone-sensitive prostate cancer. Risk factors and prevention strategies

  2011cites this paper
• Osteonecrosis de los maxilares: nuevas evidencias sobre su etiopatogenia

  2011cites this paper